Dialysis Precautions for Patients with Dilated Cardiomyopathy and Low Ejection Fraction
For patients with dilated cardiomyopathy and severely reduced ejection fraction (25%), slow, prolonged ultrafiltration with careful hemodynamic monitoring is essential to prevent cardiovascular collapse during dialysis.
Hemodynamic Considerations
Blood Pressure Management
- Avoid rapid ultrafiltration which can cause intradialytic hypotension in patients with low EF 1
- Monitor blood pressure frequently during dialysis (every 15-30 minutes)
- Consider setting a higher dry weight initially and gradually reducing it over multiple sessions 2
- Target a modest ultrafiltration rate (10-13 mL/kg/hour maximum) to minimize hemodynamic instability 1
Volume Management
- Consider extending dialysis time to allow for gentler fluid removal
- Implement isolated ultrafiltration sessions on non-dialysis days if needed for persistent fluid overload 2
- Monitor for signs of volume overload (jugular venous distention, peripheral edema) and volume depletion (hypotension, tachycardia) 1
- Use bioimpedance or other volume assessment tools if available to guide ultrafiltration goals
Medication Considerations
Heart Failure Medications
- Continue beneficial heart failure medications (ACEIs, beta-blockers, ARBs) but adjust timing around dialysis 1
- For patients on carvedilol, maintain therapy as it has shown benefit in dialysis patients with dilated cardiomyopathy 1
- Consider holding vasodilators on dialysis days to prevent hypotension
- Monitor for hyperkalemia with aldosterone antagonists, which should be used with extreme caution or avoided 1
Dialysis Prescription Modifications
- Use bicarbonate buffer instead of acetate to minimize cardiac depression 1
- Consider high-flux biocompatible membranes with ultrapure water 1
- Maintain dialysate sodium at 138-140 mEq/L to prevent osmotic shifts
- Consider cooler dialysate temperature (35-36°C) to improve hemodynamic stability
Monitoring During Dialysis
Cardiac Monitoring
- Consider continuous cardiac monitoring during initial dialysis sessions
- Monitor for arrhythmias which may be precipitated by electrolyte shifts
- Have emergency medications readily available (vasopressors, inotropes)
- Assess for signs of cardiac decompensation (new S3 gallop, worsening pulmonary rales)
Laboratory Monitoring
- Check electrolytes (especially potassium) before and after dialysis
- Monitor BUN and creatinine trends to assess adequacy
- Consider more frequent BNP measurements to guide volume status 1
- Adjust dialysate potassium based on pre-dialysis levels to prevent arrhythmias
Special Interventions
Midodrine Use
- Consider prophylactic midodrine (5-10 mg) 30 minutes before dialysis to prevent hypotension 1
- Titrate dose based on blood pressure response
- Contraindicated in patients with uncontrolled hypertension
Albumin Infusion
- Consider albumin infusion during dialysis if patient experiences recurrent hypotension despite other measures
- Typical dose: 100 mL of 25% albumin at the beginning of dialysis
Dialysis Schedule Modifications
Frequency and Duration
- Consider more frequent dialysis (4-5 sessions/week) with shorter duration
- Alternatively, extend dialysis time (4-5 hours) with gentler ultrafiltration rates
- For patients with severe heart failure, daily short dialysis may be preferable to conventional thrice-weekly regimens
Timing
- Schedule dialysis during daytime hours when emergency support is readily available
- Avoid dialyzing patients when they are acutely ill or hemodynamically unstable
Potential Complications and Management
Intradialytic Hypotension
- If hypotension occurs, place patient in Trendelenburg position
- Administer 100-200 mL normal saline bolus
- Temporarily reduce or stop ultrafiltration
- Consider vasopressor support if hypotension persists
Arrhythmias
- Monitor for new arrhythmias during and after dialysis
- Check electrolytes if arrhythmias develop
- Have emergency medications and defibrillator readily available
Follow-up Recommendations
- Perform serial echocardiograms to assess cardiac function response to dialysis 2
- Adjust dry weight targets based on clinical response and cardiac function
- Consider cardiology consultation for optimization of heart failure management
- Evaluate for kidney transplantation if appropriate, as this may improve cardiac outcomes
Remember that patients with dilated cardiomyopathy and low EF on dialysis have a poor prognosis, with median survival around 95 days 3. However, careful management with persistent, gentle ultrafiltration can lead to significant improvement in cardiac function, with studies showing EF improvement from a mean of 31% to 50% with proper volume management 2.